Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (U01 Clinical Trial Not Allowed)
ID: 353239Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353239

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-016.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the "Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center" under a cooperative agreement mechanism (U01). This initiative aims to enhance global understanding of re-emerging and emerging infectious diseases (EIDs) while fostering research preparedness and capacity-building in regions prone to outbreaks. The Coordination Center will facilitate collaboration among ten Research Centers and various stakeholders, managing scientific, data, resource-sharing, communication, and administrative activities during both outbreak and non-outbreak periods. The funding opportunity has an award ceiling of $1.5 million, with a project period of five years, and applications are due by June 21, 2024. Interested applicants can find more information and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-016.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AI-24-016-Full-Announcement.html
    RFA-AI-24-016.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announces a funding opportunity titled "Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center" under the cooperative agreement mechanism (U01). This initiative aims to enhance global knowledge about re-emerging and emerging infectious diseases (EIDs) while promoting research preparedness and capacity-building in relevant regions worldwide. The Coordination Center (CC) will facilitate collaboration among ten Research Centers (RCs) and various stakeholders, managing scientific, data, resource-sharing, communication, and administrative activities during outbreak and non-outbreak periods. Applications are encouraged from various eligible organizations, including higher education institutions and non-profits. The fiscal budget for FY 2025 is set at $2 million for one award, with project periods lasting five years, while the application deadline is June 22, 2024. Emphasis will be placed on data stewardship, capacity strengthening, and pilot research to develop and support the next generation of scientists in infectious disease research. This funding opportunity reflects a strategic initiative for pandemic preparedness, ensuring a comprehensive approach to infectious disease threats through collaborative research, effective management, and global engagement.
    Similar Opportunities
    Limited Competition: International epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant opportunity titled "International epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)" aimed at continuing support for the HIV IeDEA Consortium. This cooperative agreement is specifically open to renewal applications from existing IeDEA Regional Data Centers, which include institutions such as the Foundation for AIDS Research and Johns Hopkins University, among others. The initiative is crucial for gathering and analyzing HIV clinical and contextual data to address regional and global research priorities related to the HIV epidemic. The estimated total program funding is $20,665,000, with seven awards expected, and interested applicants can reach out to Lori Zimand Abramson at lzimand@niaid.nih.gov or by phone at 240-627-3212 for further information. The application process is anticipated to open with a synopsis posted on August 5, 2025, and the estimated close date for applications is December 3, 2025.
    Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Centers for AIDS Research (CFAR) program, aimed at enhancing interdisciplinary HIV/AIDS research through grants. This initiative seeks to provide administrative and shared research support, fostering collaboration and infrastructure at institutions with significant NIH-funded research bases. CFARs are expected to deliver core facilities and expertise, promoting diversity, equity, and inclusion among researchers while addressing the global HIV/AIDS epidemic. Interested applicants must submit their proposals by August 4, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking a coordinating center for the Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network through a single-source funding opportunity. This initiative aims to extend the follow-up and collection of outcome data for 25,000 participants who have received genomically informed risk assessment and management recommendations, with a focus on assessing adherence to preventative recommendations and identifying correlates of adherence across various demographics. The total estimated funding for this cooperative agreement is $1,200,000, with the application expected to be due in 2025 and the project anticipated to start on July 1, 2026. Interested applicants, specifically the Principal Investigators associated with the award issued under RFA-HG-19-015 to Vanderbilt University Medical Center, can reach out to Robb Rowley, MD, at Robb.Rowley@nih.gov or by phone at 301-827-9126 for further information.
    Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for the Developmental Centers for AIDS Research (D-CFAR) program, aimed at enhancing HIV/AIDS research through administrative support and shared resources. This initiative invites applications from eligible institutions to establish D-CFARs that will foster interdisciplinary collaboration and address gaps in research infrastructure, with a focus on supporting early career investigators. Each institution may submit one application, with potential awards totaling up to $1 million annually for a duration of five years, and applications are due by August 4, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-117.html.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.
    Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Environmental Health Sciences Core Centers Program (EHSCC), aimed at establishing research hubs that focus on environmental health science. This program seeks to enhance understanding of the impact of environmental exposures on human health, with an emphasis on interdisciplinary collaboration among investigators and community engagement, as outlined in the NIEHS Strategic Plan for 2025-2029. Eligible applicants include a variety of organizations such as higher education institutions and nonprofits, with a requirement for demonstrated peer-reviewed research funding of at least $3 million annually. The NIH plans to commit $6 million to fund up to four awards, with the earliest application submission date set for February 18, 2025, and a final close date of January 29, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for Center Core Grants (P30) to establish Developmental AIDS Research Centers (D-ARC) focused on advancing research in mental health and HIV/AIDS. The program aims to support high-impact, interdisciplinary research across various domains, including NeuroHIV, behavioral science, and implementation science, while providing essential infrastructure to foster innovation and collaboration in HIV prevention and treatment strategies. Eligible applicants may request budgets up to $750,000 per year for a maximum of four years, with a strong encouragement for entities from underrepresented backgrounds to apply. The earliest application date is July 25, 2024, with final proposals due by 5 PM local time on August 25, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)." This initiative aims to support high-risk, investigator-initiated, multi-center clinical studies by facilitating early peer review and the development of essential operational documents necessary for conducting the proposed studies. The program emphasizes the importance of addressing diseases affecting underrepresented populations and requires applicants to include a Plan for Enhancing Diverse Perspectives (PEDP) in their submissions. The maximum award amount is $225,000 per year for up to two years, with applications opening on May 9, 2025, and a submission deadline of June 10, 2027. Interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers of Excellence in Genomic Science (CEGS) program, aimed at supporting innovative, interdisciplinary research in genomic science. This program seeks to establish academic centers that will develop transformative genomic approaches to address significant biomedical challenges, with a focus on integrating advanced technological and computational methods. Each award can provide up to $1.5 million per year for a maximum of five years, with potential renewal for an additional five years, and applications are due by June 23, 2025. Eligible applicants include a range of institutions such as higher education entities, nonprofits, and various government organizations, while foreign entities are not eligible. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity for high-risk multi-center clinical study implementation planning via Cooperative Agreements (U34). This initiative aims to support the early peer review of proposed clinical studies, assess study designs, and develop essential documentation, including operational manuals, focusing on diseases relevant to NIDDK's mission. The program emphasizes health equity and inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested applicants can apply for up to $225,000 per year for a maximum of two years, with the application submission period opening on September 9, 2024, and the closing date set for June 10, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.